Home > News > Midatech gets exclusivity on noble metal nanoparticles
February 5th, 2008
Midatech gets exclusivity on noble metal nanoparticles
Abstract:
The Spanish subsidiary of UK-based biological nanoparticles specialist Midatech Group has signed a licence agreement giving it new leeway to exploit the therapeutic potential of noble metal nanoparticles.
The exclusive worldwide licence from the Universidad Complutense de Madrid and the Materials Science Institute of Seville bolsters Midatech's intellectual property (IP) portfolio and opens up a range of possible applications for nanoparticles with a noble metal (e.g., gold) core, from localised drug release to cell apoptosis achieved through radiofrequency heating technology.
This latter application is of particular interest to Midatech Andalucia, which was set up in Seville to exploit the group's IP relating to magnetic noble metal nanoparticles and their interaction with external alternating magnetic fields. The Spanish subsidiary is developing a hysteresis heating device for localised destruction of bacteria and cancerous cells.
Source:
in-pharmatechnologist.com
Bookmark:
News and information
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Patents/IP/Tech Transfer/Licensing
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone May 7th, 2013